TITLE

'Salvage' Is Key for Thousands

PUB. DATE
July 2006
SOURCE
Guide;Jul2006, Vol. 26 Issue 7, p99
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that salvage therapy is the last hope for HIV patients, whose drug regimens no longer work, in the U.S. Some physicians are trying to gain access to experimental medications while others put their patient back to previous drugs. Physician Steven Deeks stated that most patients have already developed high-level resistance when protease inhibitors were introduced.
ACCESSION #
21544031

 

Related Articles

  • Health Economics in HIV Disease: A Review of the European Literature. Youle, M.; Trueman, P.; Simpson, K. // PharmacoEconomics;1999 Supplement 1, Vol. 15 Issue 5, p1 

    The costs of providing healthcare resources for patients with HIV disease have continued to rise during the last 2 decades since the first outbreak of AIDS. Although new and effective therapies have become available during this time, and are increasingly being used, outcome measures for, and the...

  • Effect of Maintaining Highly Active Antiretroviral Therapy on AIDS Events among Patients with Late-Stage HIV Infection and Inadequate Response to Therapy. Gandhi, Tejal; Wei Wei; Amin, Kamal; Kazanjian, Powel // Clinical Infectious Diseases;3/15/2006, Vol. 42 Issue 6, p878 

    Background. We evaluated the effect of maintaining highly active antiretroviral therapy (HAART) on the development of new acquired immunodeficiency syndrome (AIDS)-related events in patients with late-stage human immunodeficiency virus (HIV) infection who had suboptimal CD4+ cell count and viral...

  • Accrued HIV evidence turns treatment dogma on its head. Check, Erika // Nature;8/21/2003, Vol. 424 Issue 6951, p866 

    Focuses on the possible health risk posed by HIV drugs in patients. Inefficacy of drugs in subduing virus in HIV positive patients; Comments of various researchers on HIV therapy; Thoughts over the distribution of drugs among various developing countries.

  • A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. Hahn, K.; Arendt, G.; Braun, J. S.; von Giesen, H.-J.; Husstedt, I. W.; Maschke, M.; Straube, E.; Schielke, E. // Journal of Neurology;Oct2004, Vol. 251 Issue 10, p1260 

    Background Painful HIV-associated sensory neuropathies (HIV-SN) are a common complication of HIV infection. The pathogenesis is unknown and the treatment very limited. Gabapentin (GBP) is effective in painful diabetic neuropathy and postherpetic neuralgia and its effectiveness on painful HIV-SN...

  • The Importance of Potency and Durability in HIV Patient Antiretroviral Therapy Preferences: A Telephone Survey. Sherer Jr., Renslow D.; Fath, Michael J.; Da Silva, Barbara A.; Nicolau, Ana-Maria; Miller, Nancy L. // AIDS Patient Care & STDs;Dec2005, Vol. 19 Issue 12, p794 

    Patients who were receiving or had received antiretroviral therapy (ART) participated in 45-minute telephone interviews to evaluate the importance of major treatment attributes. A Likert scale was used to quantify and rate the importance of 9 ART attributes. Trade-off exercises allowed...

  • One thousand words.  // CMAJ: Canadian Medical Association Journal;3/18/2003, Vol. 168 Issue 6, p748 

    Reports that only five percent of people with HIV/AIDS have access to life-prolonging medication. Efforts of the organization Doctors without Borders to gather financial support for struggling economies; Consideration of commercial rights such as patent protection.

  • HIV Treatment Adherence and Sexual Functioning. Miguez-Burbano, Maria Jose; Espinoza, Luis; Lewis, John E. // AIDS & Behavior;Jan2008, Vol. 12 Issue 1, p78 

    To our knowledge, no studies have considered the bidirectional relationship between HIV infected patients’ social/sexual lives and HAART adherence. To determine it’s potential impact the study sample consisted of 135 men starting HAART and being followed for 6 months. Twenty...

  • Prevalence and Clinical Implications of Interactive Toxicity Beliefs Regarding Mixing Alcohol and Antiretroviral Therapies among People Living with HIV/AIDS. Kalichman, Seth C.; Amaral, Christina M.; White, Denise; Swetsze, Connie; Pope, Howard; Kalichman, Moira O.; Cherry, Chauncey; Eaton, Lisa // AIDS Patient Care & STDs;Jun2009, Vol. 23 Issue 6, p449 

    Alcohol use is a barrier to medication adherence. Beyond the cognitive effects of intoxication, people living with HIV/AIDS who believe that alcohol should not be mixed with their medications may temporarily stop taking medications when drinking. To examine the effects of alcohol-treatment...

  • Living With HIV.  // Scholastic Choices (Teacher's Edition);May2003, Vol. 18 Issue 8, pT2 

    Profiles Alora Gale, a teenager who was diagnosed to be HIV-positive.

Share

Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics